0000313143-13-000185.txt : 20131029 0000313143-13-000185.hdr.sgml : 20131029 20131029192036 ACCESSION NUMBER: 0000313143-13-000185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131028 FILED AS OF DATE: 20131029 DATE AS OF CHANGE: 20131029 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINDOP CHRISTOPHER J CENTRAL INDEX KEY: 0001266051 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 131177482 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION INCORPORATED STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-10-28 0 0000313143 HAEMONETICS CORP HAE 0001266051 LINDOP CHRISTOPHER J 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 0 CFO & EVP Business Development Common Stock 2013-10-28 4 D 0 335.0 39.5514 D 35119 D Common Stock 2013-10-28 4 D 0 704.0 39.5518 D 34415 D Common Stock 2013-10-28 4 D 0 655.0 39.5517 D 33760 D Common Stock 2013-10-28 4 D 0 915.0 39.5514 D 32845 D Non-Qualified Stock Option (right to buy) 26.315 2009-10-23 2015-10-23 Common Stock 29412 29412 D Non-Qualified Stock Option (right to buy) 26.47 2010-10-27 2016-10-27 Common Stock 44072 44072 D Non-Qualified Stock Option (right to buy) 27.495 2011-10-27 2017-10-27 Common Stock 50190 50190 D Non-Qualified Stock Option (right to buy) 30.67 2012-10-25 2018-10-25 Common Stock 48306 48306 D Non-Qualified Stock Option (right to buy) 39.055 2013-10-24 2019-10-24 Common Stock 46498 46498 D Non-Qualified Stock Option (right to buy) 41.66 2014-10-23 2019-10-23 Common Stock 46979 46979 D Performance Shares 0.0 2017-03-31 2017-12-31 Common Stock 25000 25000 D Pursuant to a 10b5-1 Plan to cover tax liability for released shares. Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d). By: Alexander Steffan For: Christopher Lindop 2013-10-29